Loading company…
Massy, France-based maker of the Clotild connected guidewire, which identifies tissue on contact during procedures such as stroke treatment.
Sensome SAS develops medical devices, including the Clotild connected guidewire. The guidewire uses impedance-based micro-sensors and machine learning to identify tissue on contact and is used mainly in ischemic stroke treatment. Founded in 2014 and headquartered in Massy, France, the company is led by CEO Franz Bozsak. Its July 2024 Series B raised EUR 7.361 mn from Asahi Intecc, BNP Paribas Développement, Idinvest Partners, Kurma Partners and Partech.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in